Bayesian Health Achieves FDA Clearance for AI Sepsis Monitoring System
Bayesian Health has received FDA 510(k) clearance for its continuous AI sepsis monitoring system, marking the first such approval for a continuous AI sepsis monitor. This system is part of Bayesian's real-time clinical intelligence platform, designed to enhance early detection of sepsis by continuously monitoring patient data and alerting clinicians to potential issues before they become critical. The platform integrates with existing electronic health records (EHRs) to provide a proactive layer of clinical intelligence, aiming to improve patient outcomes by enabling earlier intervention. 
